Sat, June 14, 2025
Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
Wed, May 14, 2025
Tue, May 13, 2025

GSK drug's new approval sets up competition with Dupixent


//science-technology.news-articles.net/content/2 .. -approval-sets-up-competition-with-dupixent.html
Published in Science and Technology on by STAT   Print publication without navigation

And more biotech news brought to you by The Readout.

The article from STAT News dated May 23, 2025, discusses several significant developments in the biotech industry. Novo Nordisk and GSK have announced a collaboration to develop new treatments for obesity and diabetes, leveraging GSK's expertise in respiratory diseases. CRISPR Therapeutics has made strides in its prime editing technology, showing promising results in treating genetic disorders. Additionally, a new COPD treatment from Merus has shown efficacy in clinical trials, potentially offering a new option for patients. Lastly, Merck's Keytruda has been approved for use in combination with other therapies for certain types of cancer, expanding its application in oncology. These updates highlight the ongoing innovation and partnerships driving advancements in healthcare.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/23/biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout/ ]

Publication Contributing Sources